AI in Pharmaceuticals: The Engine of Business Transformation in 2026
Molecule discovery, clinical studies, and quality control are both expensive and slow, and every month of delay lands directly on the bottom line. A report on what AI shifted in pharmaceuticals through 2026, the first steps for Iranian managers, and a plain-language glossary.